Previous Article | Next Article 
Journal of Virology, October 2001, p. 9339-9344, Vol. 75, No. 19
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.9339-9344.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Development of an Avian Leukosis-Sarcoma Virus
Subgroup A Pseudotyped Lentiviral Vector
Brian C.
Lewis,1,2,*
Nachimuthu
Chinnasamy,3
Richard A.
Morgan,3 and
Harold E.
Varmus1,2
Cell Biology Program, Memorial Sloan-Kettering Cancer
Center, New York, New York 10021,1 and
Division of Basic Sciences, National Cancer
Institute,2 and Clinical Gene Therapy
Branch, National Human Genome Research
Institute,3 Bethesda, Maryland 20892
Received 16 February 2001/Accepted 23 June 2001
We are using avian leukosis-sarcoma virus (ALSV) vectors to
generate mouse tumor models in transgenic mice expressing TVA, the
receptor for subgroup A ALSV. Like other classical retroviruses, ALSV
requires cell division to establish a provirus after infection of host
cells. In contrast, lentiviral vectors are capable of integrating their
viral DNA into the genomes of nondividing cells. With the intention of
initiating tumorigenesis in resting, TVA-positive cells, we have
developed a system for the preparation of a human immunodeficiency
virus type 1 (HIV-1)-based lentiviral vector, pseudotyped with the
envelope protein of ALSV subgroup A (EnvA). The HIV(ALSV-A) vector
retains the requirement for TVA on the surface of target cells and can
be produced at titers of 5 × 103 infectious units
(IU)/ml. By inserting the central polypurine tract (cPPT) from the
HIV-1 pol gene and removing the cytoplasmic tail of
EnvA, the pseudotype can be produced at titers approaching 105 IU/ml and can be concentrated by ultracentrifugation to
titers of 107 IU/ml. HIV(ALSV-A) also infects embryonic
fibroblasts derived from transgenic mice in which TVA expression is
driven by the
-actin promoter. In addition, this lentivirus
pseudotype efficiently infects these fibroblasts after cell cycle
arrest, when they are resistant to infection by ALSV vectors. This
system may be useful for introducing genes into somatic cells in adult
TVA transgenic animals and allows evaluation of the effects of altered
gene expression in differentiated cell types in vivo.
*
Corresponding author. Mailing address: Memorial
Sloan-Kettering Cancer Center, 1275 York Ave., Box 62, New York, NY
10021. Phone: (212) 639-6362. Fax: (212) 717-3125. E-mail:
lewisb{at}mskcc.org.
Journal of Virology, October 2001, p. 9339-9344, Vol. 75, No. 19
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.9339-9344.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Jorgenson, R. L., Vogt, V. M., Johnson, M. C.
(2009). Foreign Glycoproteins Can Be Actively Recruited to Virus Assembly Sites during Pseudotyping. J. Virol.
83: 4060-4067
[Abstract]
[Full Text]
-
Seidler, B., Schmidt, A., Mayr, U., Nakhai, H., Schmid, R. M., Schneider, G., Saur, D.
(2008). A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors. Proc. Natl. Acad. Sci. USA
105: 10137-10142
[Abstract]
[Full Text]
-
El Maarouf, A., Petridis, A. K., Rutishauser, U.
(2006). Use of polysialic acid in repair of the central nervous system. Proc. Natl. Acad. Sci. USA
103: 16989-16994
[Abstract]
[Full Text]
-
Barnard, R. J. O., Narayan, S., Dornadula, G., Miller, M. D., Young, J. A. T.
(2004). Low pH Is Required for Avian Sarcoma and Leukosis Virus Env-Dependent Viral Penetration into the Cytosol and Not for Viral Uncoating. J. Virol.
78: 10433-10441
[Abstract]
[Full Text]
-
Nikolenko, G. N., Svarovskaia, E. S., Delviks, K. A., Pathak, V. K.
(2004). Antiretroviral Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Increase Template-Switching Frequency. J. Virol.
78: 8761-8770
[Abstract]
[Full Text]
-
Bromberg-White, J. L., Webb, C. P., Patacsil, V. S., Miranti, C. K., Williams, B. O., Holmen, S. L.
(2004). Delivery of Short Hairpin RNA Sequences by Using a Replication-Competent Avian Retroviral Vector. J. Virol.
78: 4914-4916
[Abstract]
[Full Text]
-
Liu, S.-L., Halbert, C. L., Miller, A. D.
(2004). Jaagsiekte Sheep Retrovirus Envelope Efficiently Pseudotypes Human Immunodeficiency Virus Type 1-Based Lentiviral Vectors. J. Virol.
78: 2642-2647
[Abstract]
[Full Text]
-
Zhang, X.-Y., La Russa, V. F., Reiser, J.
(2004). Transduction of Bone-Marrow-Derived Mesenchymal Stem Cells by Using Lentivirus Vectors Pseudotyped with Modified RD114 Envelope Glycoproteins. J. Virol.
78: 1219-1229
[Abstract]
[Full Text]
-
Lewis, B. C., Klimstra, D. S., Varmus, H. E.
(2003). The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes Dev.
17: 3127-3138
[Abstract]
[Full Text]
-
Diaz-Griffero, F., Hoschander, S. A., Brojatsch, J.
(2002). Endocytosis Is a Critical Step in Entry of Subgroup B Avian Leukosis Viruses. J. Virol.
76: 12866-12876
[Abstract]
[Full Text]
-
Sandrin, V., Boson, B., Salmon, P., Gay, W., Negre, D., Le Grand, R., Trono, D., Cosset, F.-L.
(2002). Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood
100: 823-832
[Abstract]
[Full Text]
-
Katz, R. A., Greger, J. G., Darby, K., Boimel, P., Rall, G. F., Skalka, A. M.
(2002). Transduction of Interphase Cells by Avian Sarcoma Virus. J. Virol.
76: 5422-5434
[Abstract]
[Full Text]